Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03697395 · ClinicalTrials.gov registry record · Phase 2
Advanced Immunoclinical Phenotyping of Rejection in Lung Transplant
A Phase 2 study of Chronic Rejection of Lung Transplant, sponsored by University of Virginia.
- Active
- Registry status
- Phase 2
- Development phase
- 1,200
- Enrollment target
- 1
- Study location
NCT03697395 is a Phase 2 study of Chronic Rejection of Lung Transplant that is active but no longer recruiting, run by University of Virginia. The registered enrollment target is 1,200 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03697395, a Phase 2 study of Chronic Rejection of Lung Transplant, is active but no longer recruiting, sponsored by University of Virginia.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 1,200 participants
- Enrollment target
- 1
- Study location
Study Summary
Chronic allograft rejection of the transplanted lung (CLAD) is a major health issue in patients after lung transplant. This study is a registry-forming study with concurrent tissue banking from surveillance bronchoscopy in addition to extra tissue sampling of blood and urine. Patients will be characterized by usual clinical phenotyping and the latest imaging methods so that diseased condition underlying CLAD can be better understood.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Lung transplant recipient without MRI imaging
- DRUG Lung transplant recipient with MRI imaging
Study Locations (1)
Virginia
- University of Virginia Health System - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,200 participants |
| Start Date | 2019-04-01 |
| Est. Completion | 2038-12-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03697395
The ClinicalTrials.gov registry entry for NCT03697395 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 1,200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Rejection of Lung Transplant appearing as the primary indexed condition, and to 2 interventions - of which Lung transplant recipient without MRI imaging is the first listed.
NCT03697395 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT03697395 about?
NCT03697395 is a clinical study titled "Advanced Immunoclinical Phenotyping of Rejection in Lung Transplant". Chronic allograft rejection of the transplanted lung (CLAD) is a major health issue in patients after lung transplant. This study is a registry-forming study with concurrent tissue banking from surveillance bronchoscopy in addition to extra tissue sampling of blood and urine. Patients will be charac...
What is the current status of trial NCT03697395?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 1,200 participants. The study started on 2019-04-01. Estimated completion is 2038-12-31.
What conditions does trial NCT03697395 study?
This clinical trial studies the following conditions: Chronic Rejection of Lung Transplant.
What interventions are being tested in trial NCT03697395?
The interventions under investigation include: Lung transplant recipient without MRI imaging (DIAGNOSTIC_TEST), Lung transplant recipient with MRI imaging (DRUG).
Who is sponsoring clinical trial NCT03697395?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03697395 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Rejection of Lung Transplant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.